Is GSK plc (GSK) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2025
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 20.8% / 30% | 4.5% / 30% | 6.8% / 30% | N/A | ✓ HALAL |
| DJIM | 20.8% / 33% | 4.5% / 33% | 6.8% / 33% | N/A | ✓ HALAL |
| MSCI | 28.6% / 33% | 6.2% / 33% | 9.4% / 33% | N/A | ✓ HALAL |
| S&P | 20.8% / 33% | 4.5% / 33% | 6.8% / 33% | N/A | ✓ HALAL |
| FTSE | 28.6% / 33% | 6.2% / 33% | 9.4% / 50% | N/A | ✓ HALAL |
Financial Highlights
Profitability
| Gross Margin | 72.6% | |
| Operating Margin | 18.9% | |
| Net Margin | 17.5% | |
| Return on Equity (ROE) | 43.3% | |
| Return on Assets (ROA) | 9.8% |
Cash Flow & Balance Sheet
| Operating Cash Flow | $7.7B |
| Free Cash Flow | $4.8B |
| Total Debt | $17.7B |
| Debt-to-Equity | 111.5 |
| Current Ratio | 0.8 |
| Total Assets | $61.1B |
Price & Trading
| Last Close | GBp 2,047.00 |
| 50-Day MA | GBp 2,044.46 |
| 200-Day MA | GBp 1,715.86 |
| Avg Volume | 8.9M |
| Beta | 0.3 |
|
52-Week Range
GBp 1,242.50
| |
About GSK plc (GSK)
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through Commercial Operations and Total R&D segments. The company offers specialty medicines that include oncology, respiratory/immunology, inflammation, and inhaled medicines for HIV, respiratory eosinophildriven diseases, lupus and lupus nephritis, ovarian cancer, and endometrial cancer. It also provides vaccines for Shingles, Meningitis, RSV, Seasonal Influenza, Hepatitis, Diphtheria, Tetanus, Acellular Pertussis, Rotavirus, Pertussis, Polio, Haemophilus, Invasive Diseases, Pneumonia, Acute Otitis Media, Measles, Mumps, Rubella and Chickenpox, and Human Papilloma Virus. Additionally, the company offers general medicines for asthma, COPD, bacterial infection, benign prostatic hyperplasia, allergic rhinitis, and inflammatory skin conditions. It also focuses on the discovery, development, and commercialization of oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. It has a collaboration agreement with CureVac to develop mRNA vaccines for infectious diseases. The company has a strategic alliance with AN2 Therapeutics, Inc. for the development of new therapies for TB. GSK plc was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. The company was founded in 1715 and is headquartered in London, United Kingdom.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is GSK plc (GSK) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), GSK plc is Halal. The company passes all financial ratio thresholds for debt, cash, receivables, and impermissible income. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is GSK plc's debt ratio?
GSK plc's debt ratio is 20.8% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 28.6%.
What are GSK plc's key financial metrics?
GSK plc has a market capitalization of $81.9B, trailing P/E ratio of 14.7, and revenue of $32.7B. The company maintains a gross margin of 72.6% and a net margin of 17.5%. Return on equity stands at 43.3%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.